GAIN (German Adjuvant Intergroup Node Positive) study: A phase III trial to compare idd-ETC vs. EC-TX in patients with node-positive primary breast cancer – final efficacy analysis. Volker Möbus1, Gunter von Minckwitz

Source URL: www.germanbreastgroup.de

• Prodrugs
• Cancer treatments
• Ribbon symbolism
• Oncology
• Chemotherapy regimens
• Capecitabine
• Breast cancer
• Epirubicin
• Chemotherapy
• Medicine
• Chemistry
• Organic chemistry